EBIpa: Opinions and Representations of Advanced Practice Nurses (IPA) in Nephrology in France on Clinical Research

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Completed
CT.gov ID
NCT06038877
Collaborator
(none)
11
1
2.7
4.1

Study Details

Study Description

Brief Summary

This single-center study will identify the representations and opinions of Advanced Practise Nurses (IPA) in nephrology in the Auvergne Rhône Alpes (AURA) region about clinical research. The study will consist of individual semi-directive interviews with Advanced Practise Nurses (IPA).

Condition or Disease Intervention/Treatment Phase
  • Other: Interviews
  • Other: Qualitative analysis

Study Design

Study Type:
Observational
Actual Enrollment :
11 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Opinions and Representations of Advanced Practice Nurses (IPA) in Nephrology in France on Clinical Research
Actual Study Start Date :
Oct 10, 2022
Actual Primary Completion Date :
Dec 31, 2022
Actual Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Advanced Nephrology Practice Nurses

Advanced Nephrology Practice Nurses in France will be included.

Other: Interviews
Individual semi-structured interviews

Other: Qualitative analysis
Thematic analysis of the content of responses

Outcome Measures

Primary Outcome Measures

  1. Speeches collected during semi-structured interviews [5 months]

    To explore the beliefs and attitudes of IPA in nephrology about clinical research.

Secondary Outcome Measures

  1. Evaluation of the responses to the follow-up questions [5 months]

    To identify barriers and facilitators of the involvement of this profession in clinical research.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Hold a state diploma in advanced practice nursing

  • Have been working at the health facilities for at least 3 months

  • Working in France

Exclusion Criteria:
  • Refusal to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Saint-Etienne Saint-Etienne France 42000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: Marion BONJEAN, nurse, CHU Saint Etienne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT06038877
Other Study ID Numbers:
  • IRBN922022/CHUSTE
First Posted:
Sep 15, 2023
Last Update Posted:
Sep 15, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne

Study Results

No Results Posted as of Sep 15, 2023